Insider Ledger

PLUR insider buying and SEC filings, explained

Pluri Inc. · CIK 1158780

Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov

Company profile

Exchanges
Nasdaq
Industry (SIC)
Biological Products, (No Diagnostic Substances)
State of incorporation
NV
Fiscal year end
Jun 30
Former names
PLURISTEM THERAPEUTICS INC; PLURISTEM LIFE SYSTEMS INC; AI SOFTWARE INC

Insider activity in the last 12 months

Bought
$2.1M
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0

Insider purchases and sales, last 12 months

TradedTypeWhat was filedSource
Oct 23, 2026Other purchaseAlexandre Weinstein Manieu (Director and 10% owner) bought 1,666,668 Common Stock in 2 share classes indirectly (by entity) at $1.50 ($1.3M for the 833,334 shares with a reported price) in a private placement. Holdings of Common Stock by entity up 67% to 2,083,334 shares. Not marked as a 10b5-1 plan trade.SEC filing
Filed Oct 27, 2026, 6:06 AM ET
Apr 28, 2025Purchase (code P)Alexandre Weinstein Manieu (Director and 10% owner) bought 452,702 shares indirectly at $4.61 ($2.1M), reported as a purchase (code P). New position of 452,702 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner.SEC filing
Filed Nov 20, 2025

15 routine transactions (such as grants, option exercises or tax withholding) are not listed.

Cluster buys

No cluster buys in the last 12 months.

Red flags

No red flags in the last 12 months.

Key events

No key events in the last 12 months.

8-K filings, last 12 months

FiledItemsTagSource
Oct 30, 2026, 8:30 AM ET
8-K
Material agreement (Item 1.01)
Unregistered share sale (Item 3.02)
Other event (Item 8.01)
SEC filing

Red flags are objective triggers only: the item or form filed, never an opinion.

Follow PLUR in the Insider Ledger app

A plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.

Get the app